Anne Sullivan
Chief Business Officer, Prilenia Therapeutics B.V.
- Role
- Chief Business Officer at Prilenia
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Anne Sullivan
Senior biopharmaceutical executive with over 25 years industry experience working with both private, venture-backed biotech and large, multinational, public biopharmaceuticals. Significant functional expertise in corporate development, operations, marketing and sales with foundational experience in Finance/Accounting.
Experience
Chief Business Officer
Sep 2022 — Present · Waltham, MA, US
Prilenia Therapeutics B.V. is a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders. The company\'s lead asset, pridopidine, is an oral, highly selective Sigma-1 Receptor agonist that is currently being assessed in clinical studies as a potential treatment option for people living with Huntington\'s disease as well as ALS.
Education
The Tuck School of Business at Dartmouth
MBA, General Management
College of the Holy Cross
A.B., Economics/Accounting
Skills
- Pharmaceutical Industry
- Fda
- Life Sciences
- Oncology
- Biotechnology
- Mergers & Acquisitions
- Start-Ups
- Pharmaceutical Sales
- Product Development
- Technology Transfer
- Drug Development
- Licensing
- Commercialization
- Lifesciences
- Business Development
- Managed Care
- Clinical Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.